Ann: Change in substantial holding, page-27

I agree. The lack of communication is concerning.
Are they not reporting progress or is no progress being made?
Either way, I don't like it.

The document linked below was published last week.
The decision itself is dated 13/3/23.

It states in the document:
"Date of completion of the paediatric investigation plan: By December 2023"

P/0080/2023 : EMA decision of 13 March 2023 on the acceptance of a modification of an agreed paediatric investigation plan for methoxyflurane (Penthrox and associated names) (EMEA-000334-PIP01-08-M11)
First published:
05/04/2024
https://www.ema.europa.eu/en/medicines/human/paediatric-investigation-plans/emea-000334-pip01-08-m11

I'm wondering if this indicates that the MAGPIE trial has been completed.

MEOF-002 - Methoxyflurane AnalGesia for Paediatric InjuriEs (MAGPIE)
https://clinicaltrials.gov/study/NCT03215056
https://www.clinicaltrialsregister.eu/ctr-search/trial/2016-004290-41/GB